Abstract

P241 - Atezolizumab as treatment of urothelial carcinoma in second line of metastatic disease. Experience in our institution.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call